Target intelligence / Profile preview

Intestinal barrier tight junction protein (TJ protein)

Target
TJ protein
Molecular classification
Other (multi-protein cell junction complex; not a single molecule), Integral membrane protein (e.g., occludin, claudins, JAMs), Scaffolding protein (e.g., zonula occludens: ZO-1, ZO-2, ZO-3), Immunoglobulin superfamily (JAMs)
01

Overview

Intestinal barrier tight junction proteins are multi-protein complexes that seal the spaces between adjacent epithelial cells of the gut, thereby regulating passage of ions, water, nutrients, and macromolecules via the paracellular route. Key transmembrane protein constituents include occludin, claudins, and junctional adhesion molecules (JAMs), all of which are anchored to the cytoskeleton through intracellular scaffolding proteins like zonula occludens (ZO) family (ZO-1, ZO-2, ZO-3). The dynamic architecture of tight junctions enables the intestinal barrier to respond rapidly to physiological and pathological stimuli, including inflammatory cytokines (e.g., TNF-α, IFN-γ), bacterial toxins, and dietary components. Dysfunction or disruption of tight junctions underlies a wide array of gut-related (e.g., IBD, celiac disease) and systemic (e.g., infection, autoimmunity) diseases, making individual tight junction proteins attractive targets for therapies aimed at restoring barrier integrity. The complexity of tight junction regulation, including intricate signaling pathways, cytoskeletal rearrangement, and crosstalk with immune mediators, presents both opportunities and challenges for drug development.

Other names
TJ proteinTight junction proteinIntestinal tight junction proteinBarrier-forming protein
02

Mechanism of action

Inhibition of paracellular permeability (tightening barrier function); Restoration or stabilization of TJ protein expression and localization; Modulation of cytoskeletal interactions or post-translational signaling (preventing TJ protein disassembly); Blocking pro-inflammatory cytokine-induced disruption

03

Biological functions

Maintenance of epithelial barrier integrityRegulation of paracellular permeability (ions, water, macromolecules)Cell polarity and compartmentalizationSignal transduction (interaction with cytoskeleton and signaling pathways)Modulation of immune responseRegulation of nutrient and waste transport
04

Disease associations

Inflammatory bowel disease (IBD): barrier dysfunction increases susceptibilityInfection: barrier breach facilitates pathogen invasionCancer: altered barrier may contribute to tumor progressionOther chronic inflammatory conditions (e.g., celiac disease)Neurodegenerative and systemic diseases (due to increased permeability)
05

Safety considerations

Systemic increase of barrier tightness may impair nutrient, drug, and water absorptionOver-tightening barrier could contribute to constipation or reduced drug bioavailabilityImmune system perturbation due to altered antigen samplingRestoration of barrier without addressing underlying inflammation may be insufficient
06

Interacting drugs

Larazotide acetate (modulates tight junctions, investigated for celiac disease)

4 more in the full profile.

07

Biomarkers

Levels of claudins, occludin, or ZO-1 in tissue biopsiesTransepithelial electrical resistance (TER) measurements in vitroSerum/fecal zonulin (controversially used as a permeability marker but not universally accepted)

Beyond the preview

Go deeper on Intestinal barrier tight junction protein (TJ protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal barrier tight junction protein (TJ protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call